Besponsa 00008-0100-01
Generic: Inotuzumab Ozogamicin
- Manufacturer
- Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 18, 2017
- Listing Expires
- December 31, 2027
- Application
- BLA761040
Need to source Besponsa? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Inotuzumab Ozogamicin | .25 mg/mL |
Drug Class
CD22-directed Immunoconjugate [EPC]CD22-directed Antibody Interactions [MoA]CD22-directed Immunoconjugate [EPC]
Selected Package
00008-0100-01Selected1 VIAL, SINGLE-DOSE in 1 CARTON (0008-0100-01) / 4 mL in 1 VIAL, SINGLE-DOSE